Although we have a lot of trial data for SpO2 targeting in younger preterm populations (https://t.co/tcBl0kfznh) these data shouldn't be extrapolated to older infants with established BPD. #HotTopicsNeo2023 https://t.co/nPuD7tEQn5
Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants https://t.co/yNX1zVaInK
Cibler des niveaux d'#oxygène inférieurs ou plus élevés chez les #nouveau-nés_prématurés : https://t.co/gStg1141U0
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
Low v High O2 sats Cochrane meta-analysis: 24% more NEC with lower sats. We need to understand why? https://t.co/aVNY9Qh8Hu
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
Higher SpO2 target in extreme preemies increases the average risk of mortality.Keep in mind while under anesthesia also #PedsAnes https://t.co/iRN0UzFd5U
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - https://t.co/TQXZq6DLMt https://t.co/ysrDInp7GF
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
After analyzing local data, we recently decided to use higher SpO2 targets. More risk of ROP but hopefully less NEC. #nicu #evidencebased https://t.co/s0wmcUObKs
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - https://t.co/TQXZq6DLMt https://t.co/GcXsGix02l
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - https://t.co/TQXZq6DLMt https://t.co/hhXBuTN4nS
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq6DLMt https://t.co/Ah6ungPpqR
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - https://t.co/TQXZq6DLMt https://t.co/vUjcL0i5dQ
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - ht…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
Trade-offs b/w benefits & harms need to be assessed within local settings when deciding on SpO2 targeting policies - https://t.co/TQXZq6DLMt https://t.co/9kwUbcpCic
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @Cochrane_Child: Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq…
Effects of targeting lower vs higher arterial SpO2 sat on death or disability in #preterm infants - https://t.co/TQXZq6DLMt https://t.co/8irEkeAfh7
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
RT @Cochrane_Child: New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - ht…
New #CochraneEvidence: Effects of targeting lower vs higher arterial SpO2 on death & disability in preterm infants - https://t.co/TQXZq6DLMt https://t.co/aa4N9bm73l
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @NECsociety: Important new @cochranecollab meta-analysis of several large trials - shows lower oxygen saturation targets likely increase…
Important new @cochranecollab meta-analysis of several large trials - shows lower oxygen saturation targets likely increase risk of NEC https://t.co/5HUjV78R5U
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
RT @EBNEO: New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneo…
New Cochrane review: Low v High SpO2 targets and death or disability: https://t.co/gUIpbrxqzu @LisaAskie @Cochrane_Child #ebneoalerts https://t.co/e0j1IPJCVL
Is it better to target a lower or higher level of oxygen for babies born very early? by @cochranecollab @johnfitzsimons9 @louisehendrick https://t.co/D704rahqMB
Targeting lower or higher oxygen levels in preterm infants https://t.co/lXuRBTe1kZ
Targeting lower or higher oxygen levels in preterm infants https://t.co/jryHwV58nQ
CochraneLibrary: Targeting lower or higher oxygen levels in preterm infants https://t.co/y0STKa9irj https://t.co/CeJkXhoi0O
Effects of targeting lower versus higher arterial oxygen saturations on death or disability… https://t.co/KGdBHW2MKB